Trial Profile
ASP1517 Phase 1 Clinical Study - Single and Multiple Oral Dosing of ASP1517 in Healthy Non-elderly Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2014
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 18 Sep 2014 New trial record